The high incidence and heavy disease burden of prostate cancer (PC) require accurate and
comprehensive assessment for appropriate disease management. Prostate-specific …

Prostate specific membrane antigen positron emission tomography (PSMA PET) is an
excellent molecular imaging technique for prostate cancer. Currently, PSMA PET for patients …

Background The prostate-specific antigen (PSA) has been widely used in screening and
early diagnosis of prostate cancer (PCa). However, in the PSA grey zone of 4–10 ng/ml, the …

Considering the wide range of therapeutic options for localized prostate cancer (eg, active
surveillance, radiation-beam therapy, focal therapy, and radical prostatectomy), accurate …

Purpose Prostate-specific membrane antigen (PSMA)–based PET/CT imaging has
limitations in the diagnosis of prostate cancer (PCa). We recruited 207 participants with …

Recently, researchers have proposed perilesional sampling during prostate biopsies to
avoid systematic biopsies of patients at risk of prostate cancer. The aim of our study is to …

Targeting of lesions seen on multiparametric MRI (mpMRI) improves prostate cancer (PC)
detection at biopsy. However, 20%–65% of highly suspicious lesions on mpMRI (PI-RADS …

Nuclear medicine plays an irreplaceable role in the diagnosis and treatment of tumors.
Radiopharmaceuticals are important components of nuclear medicine. Among the …

Abstract Purpose To assess 68Ga-PSMA PET/CT for detection of low-and intermediate-risk
prostate cancer (PCa), high-risk PCa in comparison with mpMRI, respectively, and to …

Background There are some limitations in the commonly used methods for the detection of
prostate cancer. There is a lack of nomograms based on multiparametric magnetic …